Mary Kathryn Abel1,2, Kaitlyn Wald3, Nikita Sinha3,4, Joseph M Letourneau3,5, Rhodel Simbulan3, Evelyn Mok-Lin3, Marcelle I Cedars3, Mitchell P Rosen3. 1. University of California, San Francisco School of Medicine, San Francisco, CA, USA. marykathryn.abel@ucsf.edu. 2. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 499 Illinois Street, 6th Floor, San Francisco, CA, 94158, USA. marykathryn.abel@ucsf.edu. 3. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 499 Illinois Street, 6th Floor, San Francisco, CA, 94158, USA. 4. Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 5. Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Abstract
PURPOSE: As the paradigm shifts towards improving cancer survivorship, an important concern for reproductive-aged women diagnosed with cancer is how their disease and its treatment will affect their future fertility. We sought to characterize pregnancy attempts and outcomes in breast cancer patients following chemotherapy. METHODS: We conducted a prospective cohort study of women diagnosed with breast cancer seen between 2010 and 2019. A questionnaire was administered following cancer treatment with questions regarding oncologic and reproductive history and attempts and method of conception. RESULTS: Of 181 participants, 46 (25.4%) attempted to conceive following chemotherapy. Thirty-five patients (76.1%) had return of ovarian function. Of those, 34 patients (mean age 32.8 years) first attempted to conceive by intercourse, and 22 (64.7%) became pregnant, resulting in 17 live births. Of the remaining 12 who did not successfully conceive through intercourse, eight went on to try other methods, resulting in five additional pregnancies and one live birth. Twelve patients (mean age 34.6 years) proceeded directly to ART; of those, eight (66.7%) became pregnant, resulting in six live births. CONCLUSION: In breast cancer patients with return of ovarian function after chemotherapy, half were able to conceive by intercourse alone. In order to maximize reproductive potential in patients who have return of ovarian function, providers should offer natural conception as a reasonable option prior to the use of cryopreserved tissue. For those who did not attempt to conceive on their own, the use of pre-treatment cryopreserved eggs or embryos had a high likelihood of success.
PURPOSE: As the paradigm shifts towards improving cancer survivorship, an important concern for reproductive-aged women diagnosed with cancer is how their disease and its treatment will affect their future fertility. We sought to characterize pregnancy attempts and outcomes in breast cancer patients following chemotherapy. METHODS: We conducted a prospective cohort study of women diagnosed with breast cancer seen between 2010 and 2019. A questionnaire was administered following cancer treatment with questions regarding oncologic and reproductive history and attempts and method of conception. RESULTS: Of 181 participants, 46 (25.4%) attempted to conceive following chemotherapy. Thirty-five patients (76.1%) had return of ovarian function. Of those, 34 patients (mean age 32.8 years) first attempted to conceive by intercourse, and 22 (64.7%) became pregnant, resulting in 17 live births. Of the remaining 12 who did not successfully conceive through intercourse, eight went on to try other methods, resulting in five additional pregnancies and one live birth. Twelve patients (mean age 34.6 years) proceeded directly to ART; of those, eight (66.7%) became pregnant, resulting in six live births. CONCLUSION: In breast cancer patients with return of ovarian function after chemotherapy, half were able to conceive by intercourse alone. In order to maximize reproductive potential in patients who have return of ovarian function, providers should offer natural conception as a reasonable option prior to the use of cryopreserved tissue. For those who did not attempt to conceive on their own, the use of pre-treatment cryopreserved eggs or embryos had a high likelihood of success.
Authors: Kutluk Oktay; Brittany E Harvey; Ann H Partridge; Gwendolyn P Quinn; Joyce Reinecke; Hugh S Taylor; W Hamish Wallace; Erica T Wang; Alison W Loren Journal: J Clin Oncol Date: 2018-04-05 Impact factor: 44.544
Authors: Frank J M Broekmans; Dominique de Ziegler; Colin M Howles; Alain Gougeon; Geoffrey Trew; Francois Olivennes Journal: Fertil Steril Date: 2009-07-08 Impact factor: 7.329
Authors: Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Kutluk H Oktay; Charles E McCulloch; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen Journal: Cancer Date: 2011-08-17 Impact factor: 6.860
Authors: Harold J Burstein; Christina Lacchetti; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen A Gelmon; Sharon H Giordano; Clifford A Hudis; Alexander J Solky; Vered Stearns; Eric P Winer; Jennifer J Griggs Journal: J Clin Oncol Date: 2018-11-19 Impact factor: 44.544
Authors: N L Henry; R Xia; M Banerjee; C Gersch; D McConnell; D Giacherio; A F Schott; M Pearlman; V Stearns; A H Partridge; D F Hayes Journal: Ann Oncol Date: 2013-04-23 Impact factor: 32.976
Authors: Richard A Anderson; David H Brewster; Rachael Wood; Sian Nowell; Colin Fischbacher; Tom W Kelsey; W Hamish B Wallace Journal: Hum Reprod Date: 2018-07-01 Impact factor: 6.918